Cargando…
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
Despite encouraging results with immune checkpoint inhibition (ICI), a large fraction of cancer patients still does not achieve clinical benefit. Finding predictive markers in the complexity of the tumor microenvironment is a challenging task and often requires invasive procedures. In our study, we...
Autores principales: | Araujo B. de Lima, Vinicius, Hansen, Morten, Spanggaard, Iben, Rohrberg, Kristoffer, Reker Hadrup, Sine, Lassen, Ulrik, Svane, Inge Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027233/ https://www.ncbi.nlm.nih.gov/pubmed/33842304 http://dx.doi.org/10.3389/fonc.2021.558248 |
Ejemplares similares
-
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
por: Borch, Annie, et al.
Publicado: (2023) -
Application of cell-free DNA for genomic tumor profiling: a feasibility study
por: Ahlborn, Lise B., et al.
Publicado: (2019) -
The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012) -
Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2018) -
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2017)